158 related articles for article (PubMed ID: 17457918)
1. The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles.
Morikawa K; Zhao Z; Date T; Miyamoto M; Murayama A; Akazawa D; Tanabe J; Sone S; Wakita T
J Med Virol; 2007 Jun; 79(6):714-23. PubMed ID: 17457918
[TBL] [Abstract][Full Text] [Related]
2. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus.
Lavillette D; Tarr AW; Voisset C; Donot P; Bartosch B; Bain C; Patel AH; Dubuisson J; Ball JK; Cosset FL
Hepatology; 2005 Feb; 41(2):265-74. PubMed ID: 15660396
[TBL] [Abstract][Full Text] [Related]
3. A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles.
Tao W; Xu C; Ding Q; Li R; Xiang Y; Chung J; Zhong J
Virology; 2009 Dec; 395(1):67-76. PubMed ID: 19793603
[TBL] [Abstract][Full Text] [Related]
4. Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins.
Ishii K; Murakami K; Hmwe SS; Zhang B; Li J; Shirakura M; Morikawa K; Suzuki R; Miyamura T; Wakita T; Suzuki T
Biochem Biophys Res Commun; 2008 Jul; 371(3):446-50. PubMed ID: 18445476
[TBL] [Abstract][Full Text] [Related]
5. The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivity.
McCaffrey K; Gouklani H; Boo I; Poumbourios P; Drummer HE
J Gen Virol; 2011 Jan; 92(Pt 1):112-21. PubMed ID: 20926639
[TBL] [Abstract][Full Text] [Related]
6. 293 cells over-expressing human ADI1 and CD81 are permissive for serum-derived hepatitis C virus infection.
Cheng JC; Yeh YJ; Pai LM; Chang ML; Yeh CT
J Med Virol; 2009 Sep; 81(9):1560-8. PubMed ID: 19626614
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 1-boraadamantaneamine derivatives with selective astrocyte vs C6 glioma antiproliferative activity. A novel class of anti-hepatitis C agents with potential to bind CD81.
Wagner CE; Mohler ML; Kang GS; Miller DD; Geisert EE; Chang YA; Fleischer EB; Shea KJ
J Med Chem; 2003 Jul; 46(14):2823-33. PubMed ID: 12825926
[TBL] [Abstract][Full Text] [Related]
8. Role of glycosaminoglycans for binding and infection of hepatitis B virus.
Leistner CM; Gruen-Bernhard S; Glebe D
Cell Microbiol; 2008 Jan; 10(1):122-33. PubMed ID: 18086046
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection.
Andréo U; Maillard P; Kalinina O; Walic M; Meurs E; Martinot M; Marcellin P; Budkowska A
Cell Microbiol; 2007 Oct; 9(10):2445-56. PubMed ID: 17517063
[TBL] [Abstract][Full Text] [Related]
10. CD81 is an entry coreceptor for hepatitis C virus.
Cormier EG; Tsamis F; Kajumo F; Durso RJ; Gardner JP; Dragic T
Proc Natl Acad Sci U S A; 2004 May; 101(19):7270-4. PubMed ID: 15123813
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein.
Heo TH; Lee SM; Bartosch B; Cosset FL; Kang CY
Virus Res; 2006 Oct; 121(1):58-64. PubMed ID: 16725222
[TBL] [Abstract][Full Text] [Related]
12. Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry.
Voisset C; Lavie M; Helle F; Op De Beeck A; Bilheu A; Bertrand-Michel J; Tercé F; Cocquerel L; Wychowski C; Vu-Dac N; Dubuisson J
Cell Microbiol; 2008 Mar; 10(3):606-17. PubMed ID: 17979982
[TBL] [Abstract][Full Text] [Related]
13. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor.
Bartosch B; Vitelli A; Granier C; Goujon C; Dubuisson J; Pascale S; Scarselli E; Cortese R; Nicosia A; Cosset FL
J Biol Chem; 2003 Oct; 278(43):41624-30. PubMed ID: 12913001
[TBL] [Abstract][Full Text] [Related]
14. A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry.
Drummer HE; Boo I; Maerz AL; Poumbourios P
J Virol; 2006 Aug; 80(16):7844-53. PubMed ID: 16873241
[TBL] [Abstract][Full Text] [Related]
15. Significance of palmitoylation of CD81 on its association with tetraspanin-enriched microdomains and mediating hepatitis C virus cell entry.
Zhu YZ; Luo Y; Cao MM; Liu Y; Liu XQ; Wang W; Wu DG; Guan M; Xu QQ; Ren H; Zhao P; Qi ZT
Virology; 2012 Aug; 429(2):112-23. PubMed ID: 22560863
[TBL] [Abstract][Full Text] [Related]
16. Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells.
Meyer K; Basu A; Ray R
Virology; 2000 Oct; 276(1):214-26. PubMed ID: 11022009
[TBL] [Abstract][Full Text] [Related]
17. Impact of single nucleotide polymorphisms in the essential HCV entry factor CD81 on HCV infectivity and neutralization.
Deest M; Westhaus S; Steinmann E; Manns MP; von Hahn T; Ciesek S
Antiviral Res; 2014 Jan; 101():37-44. PubMed ID: 24211330
[TBL] [Abstract][Full Text] [Related]
18. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.
Gottwein JM; Scheel TK; Hoegh AM; Lademann JB; Eugen-Olsen J; Lisby G; Bukh J
Gastroenterology; 2007 Nov; 133(5):1614-26. PubMed ID: 17983807
[TBL] [Abstract][Full Text] [Related]
19. Diverse CD81 proteins support hepatitis C virus infection.
Flint M; von Hahn T; Zhang J; Farquhar M; Jones CT; Balfe P; Rice CM; McKeating JA
J Virol; 2006 Nov; 80(22):11331-42. PubMed ID: 16943299
[TBL] [Abstract][Full Text] [Related]
20. Early steps of the hepatitis C virus life cycle.
Dubuisson J; Helle F; Cocquerel L
Cell Microbiol; 2008 Apr; 10(4):821-7. PubMed ID: 18081727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
